{"expires": 1766443056, "value": "{\"moat_score\": 0.8, \"reasoning\": \"Alnylam's high gross margin and operating margin indicate a strong competitive position, while its high P/E ratio and low debt/equity ratio suggest investors have high growth expectations, typical of companies with strong moats in the healthcare sector, particularly in biotechnology where patents and R&D capabilities can provide sustainable advantages.\"}"}